Understanding the Role of Interleukin-6 in Huntington's Disease
2021-08-14
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Understanding the Role of Interleukin-6 in Huntington's Disease
Alternative title
Authors
Published Date
2021-08-14
Publisher
Type
Presentation
Abstract
Loss of MSNs in HD is accompanied by increased inflammatory cytokines like Interleukin-6 (IL-6), a major mediator of inflammatory responses throughout the body including the central nervous system (CNS) (Yang, et al., 2014 and Erta, et al., 2012)(Lois, et al., 2018). However, the primary source of IL-6 production in the striatum is still unknown. Preliminary data that I have gathered conducting immunofluorescence (IF) analyses in brain slices obtained from a symptomatic HD mouse model showed that IL-6 is present in both MSNs and other unidentified striatal cells. These unidentified cells are characterized as being larger than MSNs and presented higher concentration of IL-6 in their cytoplasm.
Keywords
Description
Related to
Replaces
License
Series/Report Number
Funding information
This research was supported by the Undergraduate Research Opportunities Program (UROP).
Isbn identifier
Doi identifier
Previously Published Citation
Other identifiers
Suggested citation
Sawyer, Jake K. (2021). Understanding the Role of Interleukin-6 in Huntington's Disease. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/223080.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.